MNM Diagnostics Revenue and Competitors

Poznań,

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • MNM Diagnostics's estimated annual revenue is currently $490k per year.(i)
  • MNM Diagnostics's estimated revenue per employee is $70,000

Employee Data

  • MNM Diagnostics has 7 Employees.(i)
  • MNM Diagnostics grew their employee count by -71% last year.

MNM Diagnostics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M4N/AN/AN/A
#2
$3.4M307%N/AN/A
#3
$27M17526%N/AN/A
#4
$7.7M610%N/AN/A
#5
$175.6M877-6%$91.2MN/A
#6
$1.5M18-5%N/AN/A
#7
$2M20N/AN/AN/A
#8
$0.2M3-70%N/AN/A
#9
$32M20841%N/AN/A
#10
$1.3M16-33%N/AN/A
Add Company

What Is MNM Diagnostics?

MNM Diagnostics is a diagnostics company based in Poland. We help people understand their genetic background through whole genome sequencing and advanced software tools for rapid and effective early disease diagnosis, prediction and prognosis. We believe that every person should have access to the information encoded in his/her DNA. By combining whole genome sequencing (WGS) technology with our unique algorithms, we decipher this information and create personalized diagnostics for individual patients. Our team of creative and enthusiastic people combines expertise in DNA chemistry and cell biology, with AI and machine learning to provide cutting-edge genome analysis and develop new approaches to personalised medicine. Knowing that information about how to fight patient's disease is hidden in their genome, we help patients to recognise the cause of their disease and choose the right strategy to fight it.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$490k

Revenue (est)

-71%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MNM Diagnostics News

2022-04-17 - Polski start-up wdro?y now? metod? leczenia raka jajnika

Pozna?ski start-up naukowy MNM Diagnostics opracuje i wdro?y test genetyczny umo?liwiaj?cy udzielenie skuteczniejszej pomocy pacjentkom z...

2022-03-30 - The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%

Clinical Diagnostics held the largest share during the forecast period. ... product portfolios, recent developments, and MNM overview.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M176%N/A
#2
$1.4M18-5%N/A
#3
$1.9M19-5%N/A
#4
$3.7M210%N/A
#5
$4.5M21-5%N/A